SJS Investment Consulting’s Editas Medicine EDIT Stock Holding History

SJS Investment Consulting’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17K	Buy	360 +318	+757%	+$929	﹤0.01%	1974
2026 Q1	$104	Buy	+42	New	+$89	﹤0.01%	2128

Other funds holding EDIT

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

TWM

Thrive Wealth Management Audubon, Pennsylvania $787M AUM 23.6% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

DIM

DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

IFG

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

SJS Investment Consulting's EDIT Position: Q2 2026 in Review

SJS Investment Consulting increased its Editas Medicine (EDIT) stake by 757% in Q2 2026, buying an estimated $929 and bringing the position to 360 shares worth $1.17K. The position accounts for ﹤0.01% of the portfolio, ranked #1974.

SJS Investment Consulting first reported a position in EDIT in Q1 2026 and has held it in 2 quarters since. 49 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

SJS Investment Consulting held 360 shares of Editas Medicine worth $1.17K as of Q2 2026.
SJS Investment Consulting bought 318 Editas Medicine shares in Q2 2026, an estimated $929.
Editas Medicine made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1974 holding.
SJS Investment Consulting first reported a position in Editas Medicine in Q1 2026 and has held it in 2 quarters since.
49 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.